Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ELEV

Elevation Oncology (ELEV) Stock Price, News & Analysis

Elevation Oncology logo

About Elevation Oncology Stock (NASDAQ:ELEV)

Key Stats

Today's Range
$0.37
$0.37
50-Day Range
$0.36
$0.39
52-Week Range
$0.22
$3.09
Volume
N/A
Average Volume
1.18 million shs
Market Capitalization
$21.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.62
Consensus Rating
Hold

Company Overview

Receive ELEV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elevation Oncology and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ELEV Stock News Headlines

Elevation Oncology Terminates License Agreement with CSPC
10 Cheap Stocks Ready to Explode
Remember when Nvidia was trading at $60? Yeah, me too. Painful, right? While early investors turned every $10,000 into $100,000+, most of us watched from the sidelines, thinking we'd already missed the boat. Here's the thing though... The AI revolution isn't over. It's just getting started.tc pixel
See More Headlines

ELEV Stock Analysis - Frequently Asked Questions

Elevation Oncology, Inc. (NASDAQ:ELEV) posted its earnings results on Thursday, May, 15th. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by $0.04.

Elevation Oncology (ELEV) raised $1 billion in an initial public offering on Friday, June 25th 2021. The company issued 63,000,000 shares at $15.00-$17.00 per share.

Elevation Oncology's top institutional investors include Opaleye Management Inc. (2.44%), Deltec Asset Management LLC (2.43%), Rangeley Capital LLC (1.53%) and Geode Capital Management LLC (0.91%).
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Elevation Oncology investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Tesla (TSLA), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
5/15/2025
Today
9/24/2025
Next Earnings (Estimated)
11/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ELEV
CIK
1783032
Fax
N/A
Employees
40
Year Founded
2019

Price Target and Rating

High Price Target
$7.00
Low Price Target
$0.70
Potential Upside/Downside
+616.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.82)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$44.49 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-74.68%
Return on Assets
-48.14%

Debt

Debt-to-Equity Ratio
0.67
Current Ratio
19.40
Quick Ratio
19.40

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.02 per share
Price / Book
0.36

Miscellaneous

Outstanding Shares
59,220,000
Free Float
54,427,000
Market Cap
$21.62 million
Optionable
Optionable
Beta
1.48

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:ELEV) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners